WhatA carrier-grade caller reputation API that scores every inbound call based on verified origin, call patterns, and crowdsourced spam reports — letting phones block bad actors without requiring full KYC.
SignalCommenters repeatedly express that the real problem is spam and scam calls, and that STIR/SHAKEN has failed to deliver on its promise years after mandated deployment — they want calls traceable to accountable parties without mass surveillance.
Why NowSTIR/SHAKEN adoption has stalled, AI-generated voice scams are exploding, and the FCC's KYC proposal is a regulatory admission that current anti-spam measures have failed.
MarketTelcos and enterprise phone systems paying per-query or via licensing; $2B+ spam filtering market. Hiya and Nomorobo exist but lack carrier-level attestation integration.
MoatProprietary call graph data that improves with every carrier partnership, creating a compounding data advantage that new entrants cannot replicate.
CRISPR Delivery Platform for Solid Tumor TherapeuticsP7/10A biotech company focused specifically on solving the delivery problem for CRISPR-based cancer therapies, developing novel lipid nanoparticle or viral vector systems that can efficiently transport CRISPR payloads to solid tumors in vivo.
CRISPR Cancer Diagnostics for Undruggable MutationsP6/10A diagnostic platform that profiles patients' tumors for the specific genomic amplifications and mutations that CRISPR-shredding approaches can target, enabling oncologists to match patients to emerging CRISPR therapies.
Biotech Translation Tracker for Informed InvestorsC5/10A platform that tracks the real progress of preclinical and clinical-stage biotech breakthroughs — from lab results through delivery challenges, trial phases, and regulatory milestones — giving investors and patients an honest, hype-free assessment of how close therapies actually are to market.
Viral Vector Therapy Development Platform as ServiceC6/10A contract development platform that helps biotech startups and academic labs design, optimize, and manufacture viral vector (AAV/lentivirus) delivery systems for gene therapies, positioning as the picks-and-shovels play in gene therapy.
Automated Cost Guardrails for AI Agent OperationsP7/10A middleware layer that sits between AI agents and cloud/API services, enforcing hard spending limits, rate controls, and anomaly detection before any resource is consumed.
Prepaid Spending Caps for Cloud and API ServicesC6/10A financial wrapper service that lets developers provision hard-capped, prepaid budgets for cloud and API usage — once the balance hits zero, all calls stop instantly.